WealthShield’s AbbVie ABBV Stock Holding History

WealthShield’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$406K	Buy	+4,138	New	+$390K	0.25%	77

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

WealthShield's ABBV Position: Q4 2017 in Review

WealthShield opened a new position in AbbVie (ABBV) in Q4 2017: 4,138 shares worth $406K. The stake represents 0.25% of the portfolio and ranks #77 among its holdings.

2,001 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

WealthShield held 4,138 shares of AbbVie worth $406K as of Q4 2017.
AbbVie was a new WealthShield position in Q4 2017.
AbbVie made up 0.25% of WealthShield's portfolio in Q4 2017, its #77 holding.
2,001 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on WealthShield's 13F filing for Q4 2017, filed 14 Feb 2018.